
1. virus res. 2012 apr;165(1):112-7. doi: 10.1016/j.virusres.2012.02.002. epub 2012 
feb 10.

replication human coronaviruses sars-cov, hcov-nl63 hcov-229e inhibited
by drug fk506.

carbajo-lozoya j(1), müller ma, kallies s, thiel v, drosten c, von brunn a.

author information: 
(1)max-von-pettenkofer institute, ludwig-maximilians-university (lmu) munich,
pettenkoferstrasse 9a, 80336 münchen, germany.

recent research shown coronavirus (cov) replication depends active
immunophilin pathways. demonstrate drug fk506 (tacrolimus)
inhibited strongly growth human coronaviruses sars-cov, hcov-nl63 and
hcov-229e low, non-cytotoxic concentrations cell culture. shown by
plaque titration, qpcr, luciferase- green fluorescent protein (gfp) reporter 
gene expression, replication diminished several orders magnitude.
knockdown cellular fk506-binding proteins fkbp1a fkbp1b caco2 cells
prevented replication hcov-nl63, suggesting requirement members
of immunophilin family virus growth.

copyright © 2012 elsevier b.v. rights reserved.

doi: 10.1016/j.virusres.2012.02.002 
pmcid: pmc7114512
pmid: 22349148  [indexed medline]

